CMI_LatestReportOrientedBlogs

Treatment Resistant Depression Market Treatment resistant depression refers to a major depressive episode that fails to respond adequately to adequate pharmacotherapy with antidepressants. Factors such as genetic predisposition and other psychiatric comorbidities may contribute to treatment resistant depression. There is need for newer therapeutic options for patients suffering from treatment resistant depression as existing therapies have limited efficacy.  The global Treatment Resistant Depression Market is estimated to be valued at US$ 1220.12 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Rising disease prevalence presents a high growth opportunity for players in treatment resistant depression market. It is estimated that nearly 30% of patients diagnosed with major depressive disorder do not respond to initial antidepressant therapy. This non-resp

Veterinary Drugs Compounding Market The Veterinary Drugs Compounding Market is estimated to be valued at US$ 1313.04 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Veterinary drugs compounding involves customizing medication for animals according to their needs. This includes modifying dosage form, flavors, and strengthening or decreasing the potency of the drug. Compounded drugs help address allergies, intolerances and problems associated with swallowing pills in animals. They provide an alternative treatment option and help improve animals' quality of life. Market key trends: One of the major trends fueling the growth of veterinary drugs compounding market is rising pet ownership across the world. According to APPA National Pet Owners Survey conducted in 2021, over 90.5 million cats and 79.7 million dogs are kept as pets in the United States alone.

Veterinary Oncology Market According to an American Veterinary Medical Association survey in 2017, nearly 6 million dogs were diagnosed with cancer in the U.S., with approximately half of dogs over the age of 10 developing cancer. Veterinary oncology focuses on diagnosis, clinical management, treatment and monitoring of cancer in companion animals and zoological species. Veterinary oncology involves treatments such as chemotherapy, radiation therapy, immunotherapy, surgery and targeted therapy for companion animal cancers. Chemotherapy drugs are commonly used for various cancers like lymphoma, mammary cancer, mast cell tumors, osteosarcomas etc. Radiation therapy is used as an adjuvant therapy to surgery or chemotherapy. Developments in targeted therapies and immunotherapies are creating new options for cancer treatment in pets. The Veterinary Oncology Market is estimated to be valued at US$ 657.42 Mn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to

U.S. Opioids Market  The U.S. Opioids Market is estimated to be valued at US$ 17180.89 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Opioids are a class of drugs that include prescription pain relievers such as oxycodone, hydrocodone, codeine, morphine, fentanyl and others. They work by binding to opioid receptors in the brain and are commonly prescribed to treat moderate to severe pain. However, prolonged use may lead to dependency and addiction. They are available in various formulations such as tablets, capsules, films, patches and injectables. Market Dynamics: The increase in the prevalence of chronic pain disorders such as arthritis, cancer, migraine and back pain has emerged as a key factor driving the demand for opioids in the U.S. According to the Centers for Disease Control and Prevention (CDC), around 20.4% of the U.S. adult population suff

Ophthalmic Compounding Pharmacies Market The U.S. Ophthalmic Compounding Pharmacies Market is estimated to be valued at US$ 241.67 Mn or Mn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Ophthalmic compounding pharmacies combine prescribed ingredients into customized medications to meet specific needs of patients. They compound topical medications such as eye drops, ointments, and creams used in the treatment of glaucoma, dry eyes, infections, and allergies. The customized medications are alternatives for patients who are unable to use commercially available products due to allergy or intolerance. Market Dynamics: Increasing preference for personalized medication is a key driver boosting growth of the U.S. ophthalmic compounding pharmacies market. Customized formulations allow doctors to precisely tailor medication dosages and therapeutic ingredients bas

India And Oman Pharmaceutical Industry Market The India And Oman Pharmaceutical Industry Market is estimated to be valued at US$ 59924.05 Mn or Bn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The pharmaceutical industry in India and Oman covers a wide range of therapeutic categories including cardiovascular, anti-infective, anti-diabetic, analgesics, gastro intestinal, vitamins and dermatologicals. Major products in the market include prescription and OTC drugs for treating various chronic as well as acute diseases. India accounts for the largest share in the market owing to its strong generic drug manufacturing capabilities. Oman imports a large share of its pharmaceutical requirements from India. Market Dynamics: Growth in the geriatric population suffering from chronic diseases is a key driver for the pharmaceutical market in India and Oman. As per